• No results found

Matrix metalloproteinases in gastric inflammation and cancer : clinical relevance and prognostic impact Kubben, F.J.G.M.

N/A
N/A
Protected

Academic year: 2021

Share "Matrix metalloproteinases in gastric inflammation and cancer : clinical relevance and prognostic impact Kubben, F.J.G.M."

Copied!
11
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

Matrix metalloproteinases in gastric inflammation and

cancer : clinical relevance and prognostic impact

Kubben, F.J.G.M.

Citation

Kubben, F. J. G. M. (2007, September 27). Matrix metalloproteinases in gastric inflammation and cancer : clinical relevance and prognostic impact.

Retrieved from https://hdl.handle.net/1887/12356

Version: Corrected Publisher’s Version

License: Licence agreement concerning inclusion of doctoral thesis in the Institutional Repository of the University of Leiden

Downloaded from: https://hdl.handle.net/1887/12356

Note: To cite this publication please use the final published version (if applicable).

(2)

Matrix Metalloproteinases in Gastric

Infl ammation and Cancer

Clinical Relevance and Prognostic Impact

Frank Kubben

(3)

Matrix Metalloproteinases in Gastric Infl ammation and Cancer Clinical Relevance and Prognostic Impact

Kubben, Frank J.G.M.

Thesis, University of Leiden -with references- with summary in Dutch and English ISBN 978-90-8559-299-0

NUR 878

Cover: Mount Etna, Sicily, Italy Cover Photo: Thijs Kubben

Layout and printing: Optima Grafi sche Communicatie, Rotterdam

© 2007 F.J.G.M. Kubben, Leiden, The Netherlands

All rights reserved. No part of this thesis may be reproduced or transmitted in any form, by any means, electronic or mechanical, without prior written permission of the author or the publisher(s), when appropiate.

The publication of this thesis was fi nancially supported by Abbott B.V., AstraZeneca B.V., Ferring B.V., Janssen-Cilag B.V., Novartis Oncology, Nycomed B.V., Schering-Plough B.V., Tramedico B.V.

and UCB Pharma B.V.

(4)

Matrix Metalloproteinases in Gastric

Infl ammation and Cancer

Clinical Relevance and Prognostic Impact

Proefschrift

ter verkrijging van

de graad van Doctor aan de Universiteit Leiden, op gezag van Rector Magnifi cus prof.mr. P.F. van der Heijden,

volgens besluit van het College voor Promoties te verdedigen op donderdag 27 september 2007

klokke 13.45 uur

door

François Jozef Gerard Marie Kubben geboren te Geleen

in 1962

(5)

Promotiecommissie

Promotor:

Prof.dr. C.B.H.W. Lamers Co-promotores:

Dr. C.F.M. Sier Dr.ir. H.W. Verspaget Referent:

Prof.dr. J.B.M.J. Jansen, Universitair Medisch Centrum St. Radboud, Nijmegen Overige leden:

Prof.dr. E.J. Kuipers, Erasmus Medisch Centrum, Rotterdam Prof.dr. C.J.H. van de Velde

(6)

Voor mijn ouders Aan Ellen en Thijs

(7)
(8)

Contents

Abbreviations 9

Chapter 1

General introduction 11

Chapter 2

Mucosal gelatinases MMP-2 and MMP-9 in Helicobacter pylori-associated gastritis

37

Chapter 3

Eradication of Helicobacter pylori infection favourably aff ects altered gastric Helicobacter pylori infection favourably aff ects altered gastric Helicobacter pylori mucosal MMP-9 levels

Helicobacter 2007, in press

53

Chapter 4

Tissue levels of matrix metalloproteinases MMP-2 and MMP-9 are related to the overall survival of patients with gastric carcinoma

British Journal of Cancer 1996; 74: 413-417

67

Chapter 5

Matrix metalloproteinase-2 is a consistent prognostic factor in gastric cancer British Journal of Cancer 2006; 94: 1035-1040

79

Chapter 6

Clinical evidence for a protective role of lipocalin-2 against MMP-9 autodegradation and the impact for gastric cancer

European Journal of Cancer 2007, in press

93

Chapter 7

Clinical impact of MMP and TIMP gene polymorphisms in gastric cancer British Journal of Cancer 2006; 95: 744-751

111

Chapter 8

Summarizing discussion 131

Chapter 9

Samenvattende discussie 145

(9)

8 Contents

List of publications 155

Nawoord 161

Curriculum vitae 167

(10)

Abbreviations

ABC, avidin biotin complex

ADAMs, a disintegrin and metalloproteinases

ADAMTSs, a disintegrin and metalloproteinases with thrombospondin motifs APMA, p-aminophenylmercuric acetate

ARMS, amplifi cation refractory mutation system BIA, bioactivity assay

BSA, bovine serum albumin CI, confi dence interval ECM, extracellular matrix

ELISA, enzyme-linked immunosorbent assay

EMMPRIN, extracellular matrix metalloprproteinase inducer ERK, extracellular signal-regulated kinase

F, female

FDA, Food and Drug Administration

HNL, human neutrophil lipocalin, also named NGAL Hp, Helicobacter pylori

HR, hazard ratio

HRP, horseradish peroxidase kDa, kilo Dalton

M, male

MALT, gastric mucosa associated lymphoid tissue MMPs, matrix metalloproteinases

MPO, myeloperoxidase

mRNA, messenger ribonucleic acid

MT-MMPs, membrane-type matrix metalloproteinases NA, not applicable

ND, not defi ned

NGAL, neutrophil gelatinase-associated lipocalin, also named HNL NS, non signifi cant

NSAIDs, non-steroidal anti-infl ammatory drugs PBS, phosphate-buff ered saline

PCR, polymerase chain reaction

PUMP-1, putative matrix metalloproteinase-1 (MMP-7) RFLP, restriction fragment length polymorphism S-2444, pyro-Glu-Gly-Arg-p-nitroanilide

SEM, standard error of the mean SNP, single nucleotide polymorphism

(11)

10 Abbreviations

TBS, tris-buff ered saline

TIMPs, tissue inhibitors of metalloproteinases TNM, tumour node metastasis

VEGF, vascular endothelial growth factor WHO, World Health Organisation

Referenties

GERELATEERDE DOCUMENTEN

Matrix metalloproteinases (MMP) and the tissue inhibitors of metalloproteinases (TIMP) are involved in the (etio)pathogenesis of CD and may thereby also affect

License: Licence agreement concerning inclusion of doctoral thesis in the Institutional Repository of the University of Leiden Downloaded.

Role of matrix metalloproteinase, tissue inhibitor of metalloproteinase and tumor necrosis factor-Į single nucleotide gene polymorphisms in inflammatory bowel disease. World

We studied the genotype distribution and allele frequencies of SNPs of MMP-2, -7, -8 and -9 and TIMP-1 and -2 in gastric cancer patients in relation to tumour progression,

NGAL and MMP-9/NGAL complexes were determined in tissue homogenates from the same 81 gastric cancer patients analyzed in chapter 5 using specifi c ELISAs and bioactivity assays

MMP-2, MMP-7, MMP-8, MMP-9, NGAL, MMP-9/NGAL complexen en TIMP-1 bleken signifi cant verhoogd te zijn in tumorweefsel van patiënten met een maagcarcinoom in vergelijking met

Matrix metalloproteinases in gastric inflammation and cancer : clinical relevance and prognostic impact..

Helicobacter pylori veroorzaakte chronische gastritis is er Helicobacter pylori veroorzaakte chronische gastritis is er Helicobacter pylori sprake van verhoogde MMP-9 waarden